Literature DB >> 23722513

Recurrent pregnancy loss in a woman with NLRP7 mutation: not all molar pregnancies can be easily classified as either "partial" or "complete" hydatidiform moles.

Lucia Brown1, Sharon Mount, Ramesh Reddy, Rima Slim, Cheung Wong, Vaidehi Jobanputra, Patrick Clifford, Laura Merrill, Stephen Brown.   

Abstract

Recurrent hydatidiform moles is an uncommon occurrence. Over the past decade, genetic studies of women with multiple recurrent molar pregnancies have revealed that maternal mutations in two different genes, NLRP7 and C6orf221, result in recurrent moles. We report a 23 year old woman, born of unrelated parents, who has experienced three molar pregnancies in succession. Whilst the first pregnancy was classified as a complete hydatidiform mole, the second and third moles defied classification as complete or partial mole using conventional histology, p57 nuclear staining pattern and ploidy studies. Molecular and cytogenetic studies proved that all three molar pregnancies were diploid and biparental in origin. Gene sequencing analysis showed that the patient is homozygous for a previously described mutation in NLRP7. A SNP microarray ruled out the presence of deletion of the NLRP7 locus. This case draws attention to the fact that recurrent molar pregnancies may be the result of specific, identifiable gene mutations, even in patients from non-consanguineous backgrounds. When pathologists encounter patients with molar pregnancies that are diploid and p57 negative and yet have fetal elements such as nucleated red blood cells or immature fetal tissues, it should heighten their suspicion of a possible genetic basis and appropriate molecular genetic workup performed with counseling offered.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23722513     DOI: 10.1097/PGP.0b013e31826cbf6a

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  6 in total

1.  Biallelic PADI6 variants linking infertility, miscarriages, and hydatidiform moles.

Authors:  JianHua Qian; Ngoc Minh Phuong Nguyen; Maryam Rezaei; Bo Huang; YongLing Tao; XiaoFei Zhang; Qi Cheng; HanJin Yang; Ao Asangla; Jacek Majewski; Rima Slim
Journal:  Eur J Hum Genet       Date:  2018-04-25       Impact factor: 4.246

2.  Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes.

Authors:  Yassemine Khawajkie; Nawel Mechtouf; Ngoc Minh Phuong Nguyen; Kurosh Rahimi; Magali Breguet; Jocelyne Arseneau; Brigitte M Ronnett; Lori Hoffner; Felicia Lazure; Marjolaine Arnaud; Fabrice Peers; Liane Tan; Basam Abu Rafea; Monica Aguinaga; Neil S Horowitz; Asangla Ao; Seang Lin Tan; Richard Brown; William Buckett; Urvashi Surti; Karine Hovanes; Trilochan Sahoo; Philippe Sauthier; Rima Slim
Journal:  Mod Pathol       Date:  2019-12-19       Impact factor: 7.842

Review 3.  Role of NLRP7 in Normal and Malignant Trophoblast Cells.

Authors:  Roland Abi Nahed; Maya Elkhoury Mikhael; Deborah Reynaud; Constance Collet; Nicolas Lemaitre; Thierry Michy; Pascale Hoffmann; Frederic Sergent; Christel Marquette; Padma Murthi; Tiphaine Raia-Barjat; Nadia Alfaidy; Mohamed Benharouga
Journal:  Biomedicines       Date:  2022-01-24

4.  The Diagnosis of Choriocarcinoma in Molar Pregnancies: A Revised Approach in Clinical Testing.

Authors:  Lisa Duffy; Liangtao Zhang; Karen Sheath; Donald R Love; Alice M George
Journal:  J Clin Med Res       Date:  2015-10-23

Review 5.  Genetics and Epigenetics of Recurrent Hydatidiform Moles: Basic Science and Genetic Counselling.

Authors:  Ngoc Minh Phuong Nguyen; Rima Slim
Journal:  Curr Obstet Gynecol Rep       Date:  2014-01-21

6.  NLRP7 is expressed in the ovine ovary and associated with in vitro pre-implantation embryo development.

Authors:  Guangdong Li; Xiuzhi Tian; Dongying Lv; Lu Zhang; Zhenzhen Zhang; Jing Wang; Minghui Yang; Jingli Tao; Teng Ma; Hao Wu; Pengyun Ji; Yingjie Wu; Zhengxing Lian; Wei Cui; Guoshi Liu
Journal:  Reproduction       Date:  2019-11       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.